---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-112685"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:12:21.224162+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# China Pharma rescinds Dec 12 securities purchase agreement; deal void ab initio

## Summary
- On Dec 23, 2024, company and an unnamed investor agreed to rescind the Dec 12 securities purchase agreement.
- The rescission renders the agreement void from the beginning, as disclosed in prior 8-K filed Dec 13, 2024.
- No details on investor or financial impact provided; agreement termination may affect expected capital infusion.

## SEC filing metadata
- accession: 0001213900-24-112685
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390024112685/0001213900-24-112685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390024112685/ea0226033-8k_china.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-112685
- JSON: https://secwatch.observer/filing/0001213900-24-112685.json
- Plain text: https://secwatch.observer/filing/0001213900-24-112685.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.